These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34202246)

  • 1. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway.
    Tanaka M; Tóth F; Polyák H; Szabó Á; Mándi Y; Vécsei L
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34202246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis.
    Hunt C; Macedo E Cordeiro T; Suchting R; de Dios C; Cuellar Leal VA; Soares JC; Dantzer R; Teixeira AL; Selvaraj S
    Neurosci Biobehav Rev; 2020 Nov; 118():514-523. PubMed ID: 32853625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression.
    Comai S; Melloni E; Lorenzi C; Bollettini I; Vai B; Zanardi R; Colombo C; Valtorta F; Benedetti F; Poletti S
    Eur Neuropsychopharmacol; 2022 Feb; 55():96-109. PubMed ID: 34847455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
    Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
    J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis.
    Almulla AF; Thipakorn Y; Tunvirachaisakul C; Maes M
    Autism Res; 2023 Dec; 16(12):2302-2315. PubMed ID: 37909397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune-kynurenine pathway in social anxiety disorder.
    Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
    Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in kynurenine pathway metabolites after acute psychosocial stress in healthy males: a single-arm pilot study.
    La Torre D; Dalile B; de Loor H; Van Oudenhove L; Verbeke K
    Stress; 2021 Nov; 24(6):920-930. PubMed ID: 34320918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
    Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
    Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic Review.
    Fellendorf FT; Bonkat N; Dalkner N; Schönthaler EMD; Manchia M; Fuchs D; Reininghaus EZ
    Curr Top Med Chem; 2022; 22(25):2107-2118. PubMed ID: 35850653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
    Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
    Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
    Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
    Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults.
    Riazati N; Kable ME; Newman JW; Adkins Y; Freytag T; Jiang X; Stephensen CB
    Front Immunol; 2022; 13():917966. PubMed ID: 36248784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
    Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
    Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
    Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
    Neuropsychopharmacology; 2020 May; 45(6):998-1007. PubMed ID: 31940661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD
    Launay JM; Delorme R; Pagan C; Callebert J; Leboyer M; Vodovar N
    Transl Psychiatry; 2023 Dec; 13(1):380. PubMed ID: 38071324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.